Results 81 to 90 of about 351,379 (204)

Bounce effect or local recurrence after low-dose-rate brachytherapy of the prostate? When prostate-specific membrane antigen positron emission tomography–computed tomography is false positive: a case report

open access: yesJournal of Medical Case Reports
Introduction Low-dose-rate brachytherapy has been increasingly utilized as a minimally invasive treatment option in patients with low- and intermediate-risk prostate cancer.
Tamas Rozsos   +3 more
doaj   +1 more source

Molecular expression and immunotherapeutic potential of the novel tumour associated antigen T21 [PDF]

open access: yes, 2013
The application of immunotherapeutic approaches to target tumour cells by harnessing the body’s most important defence the immune system, could provide opportunities to oppose cancer.
Malhi, S.K.
core  

Expression analysis of delta-catenin and prostate-specific membrane antigen: Their potential as diagnostic markers for prostate cancer [PDF]

open access: yes, 2002
The current approach to prostate cancer diagnosis has major limitations including the inability of prostate-specific antigen (PSA) assays to accurately differentiate between prostate cancer and benign prostate hyperplasia (BPH) and the imprecision of ...
Tebay, Michelle   +13 more
core   +1 more source

Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript [PDF]

open access: yes, 2011
Genome-wide association studies (GWAS) have identified more than 30 prostate cancer (PrCa) susceptibility loci. One of these (rs2735839) is located close to a plausible candidate susceptibility gene, KLK3, which encodes prostate-specific antigen (PSA)
Castro, E.   +76 more
core   +1 more source

Metastatic prostate cancer in the modern era of PSA screening

open access: yesInternational Brazilian Journal of Urology
Introduction To characterize initial presentation and PSA screening status in a contemporary cohort of men treated for metastatic prostate cancer at our institution.
Philip A. Fontenot Jr   +9 more
doaj   +1 more source

Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts [PDF]

open access: yes, 2017
Purpose: We determined the characteristics of Chinese men undergoing initial prostate biopsy and evaluated the relationship between prostate specific antigen levels and prostate cancer/high grade prostate cancer detection in a large Chinese multicenter ...
Vickers, Andrew J   +11 more
core   +1 more source

MicroRNA-3162-5p-Mediated Crosstalk between Kallikrein Family Members Including Prostate-Specific Antigen in Prostate Cancer [PDF]

open access: yes, 2019
BACKGROUND: MicroRNAs mediate biological processes through preferential binding to the 3′ untranslated region (3′ UTR) of target genes. Studies have shown their association with prostate cancer (PCa) risk through single-nucleotide polymorphisms (SNPs ...
Srinivasan, Srilakshmi   +7 more
core   +1 more source

Prostate cancer in Australia [PDF]

open access: yes, 2013
This is the first comprehensive national report on prostate cancer in Australia, presenting an overview of the condition and analysis of key summary measures including incidence, mortality and survival.SummaryThe effect of prostate cancer is wide ...

core  

Serum total prostate-specific antigen values in men with symptomatic prostate enlargement in Nigeria: role in clinical decision-making [PDF]

open access: yes, 2014
Ikenna I Nnabugwu,1,2 Fred O Ugwumba,1 Oghenekaro A Enivwenae,2 Emeka I Udeh,1 Chris O Otene,2 Chinwe A Nnabugwu3 1Urology Unit, Department of Surgery, College of Medicine, University of Nigeria, Nsukka, 2Urology Unit, Department of Surgery, 3Department ...
Otene CO   +5 more
core  

Silodosin inhibits noradrenaline-activated transcription factors Elk1 and SRF in human prostate smooth muscle. [PDF]

open access: yes, 2012
The transcription factors Elk1 and serum response factor (SRF) are central regulators of cell cycle and phenotype in various cell types. Elk1 is activated by phosphorylation (serine-383), while activation of SRF requires its co-factor, myocardin ...
Christian G Stief   +21 more
core   +1 more source

Home - About - Disclaimer - Privacy